COMMD7
COMM domain-containing protein 7
Also known as: C20orf92, COMD7_HUMAN, dJ1085F17.3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86VX2
- Gene
- COMMD7
- Ensembl
- ENSG00000149600
- Chromosome
- 20
- Canonical length
- 200 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables NF-kappaB binding activity. Involved in negative regulation of DNA-templated transcription; negative regulation of NF-kappaB transcription factor activity; and tumor necrosis factor-mediated signaling pathway. Predicted to be located in cytoplasmic vesicle and membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
200 residues, UniProt reviewed canonical sequence.
>Q86VX2|COMMD7
1 MGRLHCTEDP VPEAVGGDMQ QLNQLGAQQF SALTEVLFHF LTEPKEVERF LAQLSEFATT
61 NQISLGSLRS IVKSLLLVPN GALKKSLTAK QVQADFITLG LSEEKATYFS EKWKQNAPTL
121 ARWAIGQTLM INQLIDMEWK FGVTSGSSEL EKVGSIFLQL KLVVKKGNQT ENVYIELTLP
181 QFYSFLHEME RVRTSMECFCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COMMD7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 62 nTPM
- heart muscle: 61 nTPM
- kidney: 59 nTPM
- cerebral cortex: 56 nTPM
- amygdala: 54 nTPM
- tongue: 51 nTPM
Single-cell type
- tuft cells: 12 nCPM
- oocytes: 4.6 nCPM
- retinal pigment epithelial cells: 4.3 nCPM
- schwann cells: 2.6 nCPM
- respiratory ionocytes: 2.5 nCPM
- megakaryocyte-erythroid progenitors: 1.5 nCPM
Immune cell
- total PBMC: 166 nTPM
- non-classical monocyte: 166 nTPM
- eosinophil: 163 nTPM
- intermediate monocyte: 144 nTPM
- myeloid DC: 123 nTPM
- basophil: 117 nTPM
Brain region
- midbrain: 36 nTPM
- cerebral cortex: 35 nTPM
- thalamus: 35 nTPM
- basal ganglia: 33 nTPM
- amygdala: 31 nTPM
- hypothalamus: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of DNA-templated transcription
- negative regulation of NF-kappaB transcription factor activity
- tumor necrosis factor-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- COMM domain
- COMM domain-containing protein 4/6/7/8
- COMM domain
- COMMD2-7/10, HN domain
- COMM domain-containing protein 7
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COMMD7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COMMD7 as an antibody target. Whether an autoantibody or antibody against COMMD7 could matter depends on whether native COMMD7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COMMD7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label COMMD7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...